Skip to main content
. 2020 Apr 24;25(8):1998. doi: 10.3390/molecules25081998

Table 3.

Methods for the detection of pathogenic bacteria in clinical settings along with respective main advantages and drawbacks.

Method Advantages Drawbacks
Conventional culturing methods
  • High reliability when thoroughly performed

  • Simplicity of protocols

  • Can indicated the contamination level in samples

  • Some instruments are now largely automated (but therefore are no longer low-cost)

  • Time consuming (up to 7 days)

  • Requires one to work in aseptic conditions: high risk of environmental contamination

  • Needs trained staff

  • Impossible to detect emerging and non-culturable pathogens

Polymerase Chain Reaction (PCR)
  • Rapid turnaround

  • Can be multiplexed to target different genes

  • Reliable in cases of high levels of contamination

  • Most tests do not distinguish live and dead bacteria

  • Protocols need a high level of expertise for the handling

  • Possible presence of PCR inhibitors in some matrices

  • Only pathogens with known sequence data can be detected

  • Contamination can lead to confusing results

  • Instruments and consumables can be expensive

Mass Spectrometry
  • Rapid turnaround

  • High throughput

  • Low cost for single analyses (but expensive device)

  • Difficult to directly use raw samples (enrichment or extraction of bacteria is often needed)

  • Only pathogens with known fingerprints can be reliably identified

Optical biosensors
  • Able to detect low bacterial concentrations in a rapid fashion

  • Information is both quantitative and qualitative

  • Protocols are simple and samples do not require laborious preparative steps

  • A lot of handling is required thus needing trained staff

  • Low throughput

Label-free biosensors
  • High sensitivity

  • Tunability of the specificity by tailoring ligands

  • Easily automated and interpreted

  • Some systems can assess the viability of bacteria

  • Easily miniaturized: integrable in pre-existing routines and devices

  • Requires to develop adequate ligands

  • Throughput depends on the system

  • Scalability towards commercial systems still not assessed

  • Varying cost depending on the technology